Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nancy M Peters"'
Autor:
Robert S. Kern, Philip D. Harvey, Nancy M. Peters, Nina R. Schooler, Craig N. Karson, Ellen Stover, Michelle Stewart, David P. Walling, Stephen R. Marder, Michael F. Green, Larry J. Seidman, Wendy Granberry, John Sonnenberg, William S. Stone, Fred Frese
Publikováno v:
American Journal of Psychiatry. 168:400-407
Because reduction of psychotic symptoms in schizophrenia does not result in adequate community functioning, efforts have shifted to other areas, such as cognitive impairment. The U.S. Food and Drug Administration requires that drugs for cognition enh
Autor:
Sanjay Dubé, Raimund Buller, Megan M. Fredrick, Nina R. Schooler, Maureen Rubin, Nancy M. Peters, Dawn I. Velligan, Judith Jaeger, Jim Mintz, Keith H. Nuechterlein, Stephen R. Marder
Publikováno v:
Schizophrenia bulletin. 38(3)
The Measurement and Treatment Research to Improve Cognition in Schizophrenia initiative was designed to encourage the development of cognitive enhancing agents for schizophrenia. For a medication to receive this indication, regulatory agencies requir
Autor:
Gail B. Cissell, E. Don Nelson, Nancy M Peters, Jeanette Mitchell, Saul S. Bloomfield, Tom P. Barden
Publikováno v:
Clinical pharmacology and therapeutics. 42(1)
Anirolac, a new nonsteroidal anti-inflammatory drug, was evaluated for relative efficacy, safety, and time course of analgesia. In a stratified, randomized, parallel, double-blind trial, 120 hospitalized women with moderate or severe postpartum uteri